214 related articles for article (PubMed ID: 20567091)
1. Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias.
Yasoda A; Nakao K
Endocr J; 2010; 57(8):659-66. PubMed ID: 20567091
[TBL] [Abstract][Full Text] [Related]
2. [Genetic basis for skeletal disease. CNP therapy for achondroplasia].
Yasoda A; Nakao K
Clin Calcium; 2010 Aug; 20(8):1212-8. PubMed ID: 20675932
[TBL] [Abstract][Full Text] [Related]
3. [Hormones and osteoporosis update. Effects of natriuretic peptides on endochondral bone growth].
Yasoda A; Nakao K
Clin Calcium; 2009 Jul; 19(7):1003-8. PubMed ID: 19567998
[TBL] [Abstract][Full Text] [Related]
4. The Local CNP/GC-B system in growth plate is responsible for physiological endochondral bone growth.
Nakao K; Osawa K; Yasoda A; Yamanaka S; Fujii T; Kondo E; Koyama N; Kanamoto N; Miura M; Kuwahara K; Akiyama H; Bessho K; Nakao K
Sci Rep; 2015 May; 5():10554. PubMed ID: 26014585
[TBL] [Abstract][Full Text] [Related]
5. Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice.
Kake T; Kitamura H; Adachi Y; Yoshioka T; Watanabe T; Matsushita H; Fujii T; Kondo E; Tachibe T; Kawase Y; Jishage K; Yasoda A; Mukoyama M; Nakao K
Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1339-48. PubMed ID: 19808910
[TBL] [Abstract][Full Text] [Related]
6. Circulating C-type natriuretic peptide (CNP) rescues chondrodysplastic CNP knockout mice from their impaired skeletal growth and early death.
Fujii T; Komatsu Y; Yasoda A; Kondo E; Yoshioka T; Nambu T; Kanamoto N; Miura M; Tamura N; Arai H; Mukoyama M; Nakao K
Endocrinology; 2010 Sep; 151(9):4381-8. PubMed ID: 20610569
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.
Yasoda A; Kitamura H; Fujii T; Kondo E; Murao N; Miura M; Kanamoto N; Komatsu Y; Arai H; Nakao K
Endocrinology; 2009 Jul; 150(7):3138-44. PubMed ID: 19282381
[TBL] [Abstract][Full Text] [Related]
8. A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-B.
Robinson JW; Dickey DM; Miura K; Michigami T; Ozono K; Potter LR
Bone; 2013 Oct; 56(2):375-82. PubMed ID: 23827346
[TBL] [Abstract][Full Text] [Related]
9. [C-type natriuretic peptide(CNP)--a novel stimulator of bone growth formed through endochondral ossification].
Yasoda A; Komatsu Y; Nakao K; Ogawa Y
Nihon Rinsho; 2004 Feb; 62 Suppl 2():77-81. PubMed ID: 15035100
[No Abstract] [Full Text] [Related]
10. Skeletal analysis of the long bone abnormality (lbab/lbab) mouse, a novel chondrodysplastic C-type natriuretic peptide mutant.
Kondo E; Yasoda A; Tsuji T; Fujii T; Miura M; Kanamoto N; Tamura N; Arai H; Kunieda T; Nakao K
Calcif Tissue Int; 2012 Apr; 90(4):307-18. PubMed ID: 22271248
[TBL] [Abstract][Full Text] [Related]
11. Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification.
Miyazawa T; Ogawa Y; Chusho H; Yasoda A; Tamura N; Komatsu Y; Pfeifer A; Hofmann F; Nakao K
Endocrinology; 2002 Sep; 143(9):3604-10. PubMed ID: 12193576
[TBL] [Abstract][Full Text] [Related]
12. Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death.
Fujii T; Hirota K; Yasoda A; Takizawa A; Morozumi N; Nakamura R; Yotsumoto T; Kondo E; Yamashita Y; Sakane Y; Kanai Y; Ueda Y; Yamauchi I; Yamanaka S; Nakao K; Kuwahara K; Jindo T; Furuya M; Mashimo T; Inagaki N; Serikawa T; Nakao K
PLoS One; 2018; 13(3):e0194812. PubMed ID: 29566041
[TBL] [Abstract][Full Text] [Related]
13. Exogenous C-type natriuretic peptide restores normal growth and prevents early growth plate closure in its deficient rats.
Hirota K; Furuya M; Morozumi N; Yoshikiyo K; Yotsumoto T; Jindo T; Nakamura R; Murakami K; Ueda Y; Hanada T; Sade H; Yoshida S; Enomoto K; Kanai Y; Yamauchi I; Yamashita T; Ueda-Sakane Y; Fujii T; Yasoda A; Inagaki N
PLoS One; 2018; 13(9):e0204172. PubMed ID: 30235256
[TBL] [Abstract][Full Text] [Related]
14. Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance.
Kanai Y; Yasoda A; Mori KP; Watanabe-Takano H; Nagai-Okatani C; Yamashita Y; Hirota K; Ueda Y; Yamauchi I; Kondo E; Yamanaka S; Sakane Y; Nakao K; Fujii T; Yokoi H; Minamino N; Mukoyama M; Mochizuki N; Inagaki N
J Clin Invest; 2017 Nov; 127(11):4136-4147. PubMed ID: 28990933
[TBL] [Abstract][Full Text] [Related]
15. Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP.
Dickey DM; Otto NM; Potter LR
J Biol Chem; 2017 Jun; 292(24):10220-10229. PubMed ID: 28450398
[TBL] [Abstract][Full Text] [Related]
16. C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.
Olney RC; Prickett TC; Espiner EA; Mackenzie WG; Duker AL; Ditro C; Zabel B; Hasegawa T; Kitoh H; Aylsworth AS; Bober MB
J Clin Endocrinol Metab; 2015 Feb; 100(2):E355-9. PubMed ID: 25387261
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.
Bartels CF; Bükülmez H; Padayatti P; Rhee DK; van Ravenswaaij-Arts C; Pauli RM; Mundlos S; Chitayat D; Shih LY; Al-Gazali LI; Kant S; Cole T; Morton J; Cormier-Daire V; Faivre L; Lees M; Kirk J; Mortier GR; Leroy J; Zabel B; Kim CA; Crow Y; Braverman NE; van den Akker F; Warman ML
Am J Hum Genet; 2004 Jul; 75(1):27-34. PubMed ID: 15146390
[TBL] [Abstract][Full Text] [Related]
18. C-type natriuretic peptide in growth: a new paradigm.
Olney RC
Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S6-14. PubMed ID: 16716628
[TBL] [Abstract][Full Text] [Related]
19. An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities.
Hannema SE; van Duyvenvoorde HA; Premsler T; Yang RB; Mueller TD; Gassner B; Oberwinkler H; Roelfsema F; Santen GW; Prickett T; Kant SG; Verkerk AJ; Uitterlinden AG; Espiner E; Ruivenkamp CA; Oostdijk W; Pereira AM; Losekoot M; Kuhn M; Wit JM
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1988-98. PubMed ID: 24057292
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
